In PCa, increased MEK5/ERK5 signalling is coupled with an increase in the growth fraction identified by Ki67 and Mcm2 expression and in the number of replication licensed cells with proliferative potential (Mcm2LI-Ki67LI). The gene discussed is MCM2; the disease is posterior cortical atrophy.